EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis

被引：0
|
作者：
Shaofei Chen
Jiarui Pu
Jie Bai
Yuping Yin
Ke Wu
Jiliang Wang
Xiaoming Shuai
Jinbo Gao
Kaixiong Tao
Guobin Wang
Hang Li
机构：
[1] Union Hospital,Department of Gastrointestinal Surgery
[2] Tongji Medical College,Department of Pediatric Surgery
[3] Huazhong University of Science and Technology,undefined
[4] Union Hospital,undefined
[5] Tongji Medical College,undefined
[6] Huazhong University of Science and Technology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 37卷
关键词：
Galectin-9; EZH2; Hepatocellular carcinoma; Proliferation; Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis
    Liu, Liang
    Li, Xiaojian
    Shi, Yan
    Chen, Hua
    AGING-US, 2021, 13 (08): : 12129 - 12142
  • [32] LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis
    Yao, Yongmei
    Liu, Yang
    Jin, Fengqin
    Meng, Zhaohua
    YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 640 - 649
  • [33] EZH2 promotes oral squamous cell carcinoma initiation and progression through epigenetic silencing of FHL1
    Cao, Wei
    Chen, Wantao
    CANCER RESEARCH, 2012, 72
  • [34] Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells
    Chien, Yi-Chung
    Chen, Jia-Ni
    Chen, Ya-Huey
    Chou, Ruey-Hwang
    Lee, Han-Chung
    Yu, Yung-Luen
    CANCERS, 2020, 12 (07) : 1 - 17
  • [35] Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
    Zeng, Taohui
    Luo, Lin
    Huang, Yuye
    Ye, Xiaoli
    Lin, Jinhai
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [36] CircPUM1 promotes hepatocellular carcinoma progression through the miR-1208/MAP3K2 axis
    Zhang, Yaqiong
    Wang, Dongguo
    Zhu, Tao
    Yu, Jin
    Wu, Xiaoyu
    Lin, Weidong
    Zhu, Minqi
    Dai, Yingjie
    Zhu, Jie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (01) : 600 - 612
  • [37] Ezh2 promotes TR beta lysine methylation-mediated degradation in hepatocellular carcinoma
    Park, Su Chan
    Lee, Ji Min
    GENES & GENOMICS, 2022, 44 (03) : 369 - 377
  • [38] METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
    Bi, Fangfang
    Qiu, Yuxiong
    Wu, Zongfeng
    Liu, Shaoru
    Zuo, Dinglan
    Huang, Zhenkun
    Li, Binkui
    Yuan, Yunfei
    Niu, Yi
    Qiu, Jiliang
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [39] METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
    Fangfang Bi
    Yuxiong Qiu
    Zongfeng Wu
    Shaoru Liu
    Dinglan Zuo
    Zhenkun Huang
    Binkui Li
    Yunfei Yuan
    Yi Niu
    Jiliang Qiu
    Cell Death Discovery, 9
  • [40] miR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2
    Yu, Wenfa
    Zhang, Guozheng
    Lu, Baocai
    Li, Jing
    Wu, Zhiyan
    Ma, Huimin
    Wang, Huimin
    Lian, Rong
    GENE, 2016, 577 (02) : 193 - 201
12345